Make sure providers know how to report Arexvy. The first vaccine for respiratory syncytial virus (RSV) in the world, according to global biopharma company GSK, has received Food and Drug Administration (FDA) approval in the United States. The FDA announced, May 3, that “Arexvy is approved for the prevention of lower respiratory tract disease caused […]
The post FDA Approves First RSV Vaccine in U.S. for 60-plus appeared first on AAPC Knowledge Center.